Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir

par Ouwerkerk-Mahadevan, Sivi, Snoeys, Jan, Peeters, Monika, Beumont-Mauviel, Maria, Simion, Alexandru
Publié dans Clin Pharmacokinet (2015)

Evaluation of the Pharmacokinetics and Renal Excretion of Simeprevir in Subjects with Renal Impairment

par Ouwerkerk-Mahadevan, Sivi, Beumont-Mauviel, Maria, Mortier, Steven, Peeters, Monika, Verloes, Rene, Truyers, Carla, Mannens, Geert, Wynant, Inneke, Simion, Alexandru
Publié dans Drugs R D (2015)

Telaprevir combination therapy in HCV/HIV co-infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysis

par Montes, Marisa, Nelson, Mark, Marie Girard, Pierre, Sasadeusz, Joe, Horban, Andrzej, Grinsztejn, Beatriz, Zakharova, Natalia, Rivero, Antonio, Lathouwers, Erkki, Janssen, Katrien, Ouwerkerk-Mahadevan, Sivi, Witek, James
Publié dans J Int AIDS Soc (2014)

Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications

par Marra, Fiona, Höner zu Siederdissen, Christoph, Khoo, Saye, Back, David, Schlag, Michael, Ouwerkerk‐Mahadevan, Sivi, Bicer, Ceyhun, Lonjon‐Domanec, Isabelle, Jessner, Wolfgang, Beumont‐Mauviel, Maria, Kalmeijer, Ronald, Cornberg, Markus
Publié dans Br J Clin Pharmacol (2018)

Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbu...

par Bourgeois, Stefan, Horsmans, Yves, Nevens, Frederik, van Vlierberghe, Hans, Moreno, Christophe, Beumont, Maria, Vijgen, Leen, van Eygen, Veerle, Luo, Donghan, Hillewaert, Vera, Van Remoortere, Pieter, van de Logt, Jolanda, Ouwerkerk-Mahadevan, Sivi
Publié dans Antimicrob Agents Chemother (2017)